BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Alibaba
BABA
|
+$1.45B |
| 2 |
Visa
V
|
+$458M |
| 3 |
Technology Select Sector SPDR Fund
XLK
|
+$431M |
| 4 |
DuPont de Nemours
DD
|
+$308M |
| 5 |
NVIDIA
NVDA
|
+$299M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$705M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$430M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$257M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$256M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$243M |
Sector Composition
| 1 | Technology | 22.57% |
| 2 | Consumer Discretionary | 13.95% |
| 3 | Healthcare | 10.5% |
| 4 | Financials | 8.72% |
| 5 | Industrials | 6.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2676
KVH Industries
KVHI
$114M
| $60K | ﹤0.01% |
6,560
+6,473
| +7,440% | +$59.2K |
|
2677
DHI Group
DHX
$143M
| $59.9K | ﹤0.01% |
15,636
-11,027
| -41% | -$42.2K |
|
2678
Organogenesis Holdings
ORGO
$617M
| $59.7K | ﹤0.01% |
17,976
-41,294
| -70% | -$137K |
|
2679
James Hardie Industries plc
JHX
$11.5B
| $59.6K | ﹤0.01% |
2,217
+1,698
| +327% | +$45.7K |
|
2680
Fidelity D&D Bancorp
FDBC
$260M
| $59.4K | ﹤0.01% |
1,223
+1,214
| +13,489% | +$59K |
|
2681
Rigel Pharmaceuticals
RIGL
$654M
| $59.2K | ﹤0.01% |
4,591
-2,334
| -34% | -$30.1K |
|
2682
Pure Cycle
PCYO
$266M
| $59.1K | ﹤0.01% |
5,369
+1,119
| +26% | +$12.3K |
|
2683
Gencor Industries
GENC
$225M
| $58.5K | ﹤0.01% |
3,755
+3,644
| +3,283% | +$56.8K |
|
|
ROSS.WS
2684
DELISTED
Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
ROSS.WS
| $58.4K | ﹤0.01% |
345,000
| – | – |
|
2685
RGC Resources
RGCO
$227M
| $58.2K | ﹤0.01% |
2,905
+2,815
| +3,128% | +$56.4K |
|
2686
MeiraGTx Holdings
MGTX
$603M
| $57.9K | ﹤0.01% |
8,617
+1,427
| +20% | +$9.59K |
|
|
AKTS
2687
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $57.8K | ﹤0.01% |
18,188
+3,664
| +25% | +$11.7K |
|
2688
Lexicon Pharmaceuticals
LXRX
$392M
| $57.6K | ﹤0.01% |
25,140
+6,588
| +36% | +$15.1K |
|
2689
Norwood Financial Corp
NWFL
$245M
| $57.1K | ﹤0.01% |
1,935
+1,921
| +13,721% | +$56.7K |
|
2690
XBiotech
XBIT
$85.4M
| $56.9K | ﹤0.01% |
9,587
+8,114
| +551% | +$48.2K |
|
2691
Sportsman's Warehouse
SPWH
$112M
| $56.9K | ﹤0.01% |
9,980
-26,134
| -72% | -$149K |
|
2692
Zai Lab
ZLAB
$3.16B
| $56.7K | ﹤0.01% |
2,045
-155,751
| -99% | -$4.32M |
|
2693
Telefonica
TEF
$29.9B
| $56.5K | ﹤0.01% |
14,008
+2,895
| +26% | +$11.7K |
|
2694
Compañía de Cervecerías Unidas
CCU
$2.18B
| $56.2K | ﹤0.01% |
+3,461
| New | +$56.2K |
|
2695
Wave Life Sciences
WVE
$1.18B
| $56.1K | ﹤0.01% |
15,400
+14,711
| +2,135% | +$53.5K |
|
2696
Cardlytics
CDLX
$49.8M
| $56K | ﹤0.01% |
8,862
-13,338
| -60% | -$84.3K |
|
2697
Mistras Group
MG
$301M
| $55.8K | ﹤0.01% |
+7,223
| New | +$55.8K |
|
2698
Scholar Rock
SRRK
$3B
| $55.8K | ﹤0.01% |
7,394
+6,488
| +716% | +$48.9K |
|
2699
Park-Ohio Holdings
PKOH
$310M
| $55.6K | ﹤0.01% |
2,925
+2,914
| +26,491% | +$55.4K |
|
2700
Xenon Pharmaceuticals
XENE
$2.86B
| $55.5K | ﹤0.01% |
1,441
+413
| +40% | +$15.9K |
|